Citation Impact
Citing Papers
A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia
2018 StandoutNobel
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
2019 StandoutScienceNobel
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
Iterative ensemble feature selection for multiclass classification of imbalanced microarray data
2016
Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
2016
Relapsing Catastrophic Antiphospholipid Syndrome: Report of Three Cases
2007
Mammalian Fe–S cluster biogenesis and its implication in disease
2014
Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure
2004 StandoutNobel
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype
2009
New agents in myelodysplastic syndromes
2006
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells
1999 Standout
The emerging role of lncRNAs in cancer
2015 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blasts
2012
Long Noncoding RNAs in Cancer Pathways
2016 Standout
Translational Control in Cancer Etiology
2012
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias
2007
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Multiple myeloma
2000 Standout
Drosophila Ribosomal Protein Mutants Control Tissue Growth Non-Autonomously via Effects on the Prothoracic Gland and Ecdysone
2011
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Refractory anemia with ring sideroblasts
2013
Apoptotic mechanisms in the control of erythropoiesis
2004
Multiple sclerosis
2008 Standout
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes
2015 StandoutNobel
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Deregulation of Genes Related to Iron and Mitochondrial Metabolism in Refractory Anemia with Ring Sideroblasts
2015
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
Dysplasia Has A Differential Diagnosis: Distinguishing Genuine Myelodysplastic Syndromes (MDS) From Mimics, Imitators, Copycats and Impostors
2012
Long non-coding RNAs: new players in cell differentiation and development
2013 Standout
The myelodysplastic syndrome.
1989
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
2017 Standout
Philadelphia Chromosome–Positive Acute Myeloid Leukemia
2007
Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders
2002
TET enzymes, TDG and the dynamics of DNA demethylation
2013 StandoutNature
Acquired mutations in TET2 are common in myelodysplastic syndromes
2009
Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis
2019 StandoutNobel
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Sickle-cell disease
2010 Standout
Non-coding RNAs in human disease
2011 Standout
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
Management of Immune Thrombocytopenic Purpura in Adults
2004
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
2003 Standout
Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models
2016
Comparing effects of mTR and mTERT deletion on gene expression and DNA damage response: a critical examination of telomere length maintenance-independent roles of telomerase
2009 StandoutNobel
Abnormal erythropoiesis and the pathophysiology of chronic anemia
2014
DNA-PKcs has KU-dependent function in rRNA processing and haematopoiesis
2020 StandoutNatureNobel
Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse
2012
Proteins related to the spindle and checkpoint mitotic emphasize the different pathogenesis of hypoplastic MDS
2013
The power plant of the cell is also a smithy: The emerging role of mitochondria in cellular iron homeostasis
2008
Sirolimus for Refractory Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review of the Treatment of Post-Transplant Autoimmune Hemolytic Anemia
2015
Therapeutic effect of androgen therapy in a mouse model of aplastic anemia produced by short telomeres
2015
Diagnosis and Management of Acquired Pure Red Cell Aplasia
2009
The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome
2012
Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status
2014
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
2012
Immune thrombocytopenic purpura in adults
2007
Treatment of pure red cell aplasia and autoimmune haemolytic anaemia in chronic lymphocytic leukaemia with Campath‐1H
2003
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells
2013
Xist RNA Is a Potent Suppressor of Hematologic Cancer in Mice
2013
Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia.
1998
MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia
2014
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
The window of therapeutic opportunity in multiple sclerosis
2005
Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: a systematic review with pooled data analysis
2012
Dyskeratosis congenita: a genetic disorder of many faces
2007
Philadelphia chromosome‐positive mixed phenotype acute leukemia in the imatinib era
2014
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Unraveling the Molecular Pathophysiology of Myelodysplastic Syndromes
2011
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Recent developments in myelodysplastic syndromes
2014
Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms
2012
Peptidic degron for IMiD-induced degradation of heterologous proteins
2019 StandoutNobel
A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation
2008
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
The new frontier of genome engineering with CRISPR-Cas9
2014 StandoutScienceNobel
Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
2008 Standout
Prognostic irrelevance of ring sideroblast percentage in World Health Organization–defined myelodysplastic syndromes without excess blasts
2012
Novel TET2 Mutations Associated With UPD4q24 in Myelodysplastic Syndrome
2009
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
How I treat acquired aplastic anemia
2012
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
1997 Standout
Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromes
2013
Exclusion of deep venous thrombosis with D-dimer testing--comparison of 13 D-dimer methods in 99 outpatients suspected of deep venous thrombosis using venography as reference standard.
2000
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
How I treat transfusional iron overload
2012
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS)
2007
Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification
2011
Learning from class-imbalanced data: Review of methods and applications
2016 Standout
A review of the current use of rituximab in autoimmune diseases
2008
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura
2011
Oxygen Sensing and Homeostasis
2015 StandoutNobel
Ribosomopathies: human disorders of ribosome dysfunction
2010
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Sudestada1, a Drosophila ribosomal prolyl-hydroxylase required for mRNA translation, cell homeostasis, and organ growth
2014 StandoutNobel
The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry
2015
How I treat autoimmune hemolytic anemias in adults
2010
Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia
2016
Management of adult idiopathic thrombocytopenic purpura.
2006
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice
2018
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Tunable protein synthesis by transcript isoforms in human cells
2016 StandoutNobel
DNA of Erythroid Origin Is Present in Human Plasma and Informs the Types of Anemia
2017
Works of Sally Killick being referenced
Guidelines for the diagnosis and management of aplastic anaemia
2009
Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS‐13
2006
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells
2010
The effect of treatment with Campath‐1H in patients with autoimmune cytopenias
2001
Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations
2007
Comparison of immunofiltration assay of plasma D‐dimer with diagnostic imaging in deep vein thrombosis
1997
Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal‐ and translation‐related genes
2008
A pilot study of antithymocyte globulin (ATG) in the treatment of patients with ‘low‐risk’ myelodysplasia
2003
Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long‐term blood transfusions
2007
Impact of previous high-dose therapy on outcome after allografting for multiple myeloma
1999
Cardiac iron overload in transfusion‐dependent patients with myelodysplastic syndromes
2011
Pilot study of HLA alloimmunization after transfusion with pre‐storage leucodepleted blood products in aplastic anaemia
1997
Gene expression profiling of CD34+ cells in patients with the 5q− syndrome
2007
Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays
2008
Sustained remission of severe resistant autoimmune neutropenia with Campath‐1H
1997
Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin
2007
Mechanisms of bone marrow progenitor cell apoptosis in aplastic anaemia and the effect of anti-thymocyte globulin: examination of the role of the Fas-Fas-L interaction
2000
Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes
2015
The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts
2008
Identification of Gene Expression–Based Prognostic Markers in the Hematopoietic Stem Cells of Patients With Myelodysplastic Syndromes
2013
Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia.
2009
Outcome of biphenotypic acute leukemia.
1999
Guidelines for the diagnosis and management of adult aplastic anaemia
2015
Fludarabine-induced tumour lysis in low-grade non-Hodgkin’s lymphoma
1997